Posted on by ScienceFather
58 / 100
Powered by Rank Math SEO

Assoc. Prof. Dr. Hui Xiong | Nanomedicine Award | Best Researcher Award

Assoc. Prof. Dr. Hui Xiong, China Pharmaceutical University, china

Hui Xiong is an accomplished researcher and associate professor at China Pharmaceutical University, specializing in the development of multifunctional nanosystems for cancer therapy. With a Ph.D. in Biotechnology, her work focuses on innovative drug delivery platforms and combination therapies targeting various aspects of tumor biology. Through her extensive research experience and numerous publications, she has made significant contributions to advancing cancer treatment strategies. Additionally, Hui Xiong has secured funding from prestigious foundations to support her groundbreaking research endeavors.

Professional Profile:

Scopus

šŸŽ“ Education and Work Background

Dr. Hui Xiong holds a Ph.D. in Biotechnology from Banasthali Vidhyapith Rajasthan, completed in 2018 with a remarkable score of 81.36%. Prior to that, she earned her M.Sc. in Biotechnology from the same institution in 2013, achieving a commendable score of 76.35%. Her academic journey began with a Bachelor’s degree in Biotechnology from Sam Higginbottom University of Agriculture, Technology and Science Prayagraj, where she graduated with an outstanding CGPA of 9.96 in 2011.

šŸ’¼ Work Experience

Dr. Hui Xiong has served as an Associate Professor in the Department of Pharmaceutics at China Pharmaceutical University (CPU) since 2017, contributing significantly to the field of pharmaceutical sciences. Prior to her current role, she worked as a Postdoctoral Researcher at CPU from 2017 to 2020, where she made notable contributions to research in pharmaceutics. Dr. Xiong embarked on her academic journey as a Ph.D. student in the same department at CPU from 2012 to 2017, showcasing her dedication to advancing pharmaceutical research. Her educational foundation was laid during her undergraduate years at the College of Pharmacy, Hubei University of Chinese Medicine, where she honed her skills and passion for the field from 2008 to 2012.

šŸ† Foundations

Dr. Hui Xiong’s research endeavors have garnered recognition and support from prestigious organizations such as the National Natural Science Foundation of China. Her innovative projects have received funding from this esteemed foundation, underscoring the significance and impact of her contributions to the field of pharmaceutical sciences. This funding serves as a testament to Dr. Xiong’s expertise and the importance of her research in advancing scientific knowledge and addressing critical challenges in the pharmaceutical industry.

Publication Top Notes:

  1. Glycolysis-non-canonical glutamine dual-metabolism regulation nanodrug enhanced the phototherapy effect for pancreatic ductal adenocarcinoma treatment – 2024
    • Published in: Journal of Colloid and Interface Science
  2. Recent Progress in Anti-Tumor Nanodrugs Based on Tumor Microenvironment Redox Regulation – 2024
    • Published in: Small
  3. Bioengineered Nanospores Selectively Blocking LC3-Associated Phagocytosis in Tumor-Associated Macrophages Potentiate Antitumor Immunity – 2023
    • Published in: ACS Nano
  4. Modified chitosan nanogel-polymersomes for oral co-delivery of oxaliplatin and rapamycin for synergistic chemotherapy – 2022
    • Published in: Journal of Drug Delivery Science and Technology
  5. Metabolic Symbiosis-Blocking Nano-Combination for Tumor Vascular Normalization Treatment – 2022
    • Published in: Advanced Healthcare Materials

 

Assoc. Prof. Dr. Hui Xiong | Nanomedicine Award | Best Researcher Award

You May Also Like